CODEXIS, INC.

For the period ended Jun 30, 2025. Filed Aug 13, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 13, 2025

CDXS$1.11+2.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. Condensed Consolidated Statements of Operations

Condensed Consolidated Statements of Operations

(In Thousands, Except Per Share Amounts)

	Three Months Ended June 30,		Six Months Ended June 30,
	2025	2024	2025	2024
Revenues:
Product revenue	$7,380	$6,259	$13,439	$15,810
Research and development revenue	7,948	1,720	9,432	9,242
Total revenues	15,328	7,979	22,871	25,052
Costs and operating expenses:
Cost of product revenue	2,098	3,462	4,830	8,317
Research and development	13,775	11,413	26,717	22,659
Selling, general and administrative	12,317	15,671	24,672	28,531
Asset impairment and other charges	—	165	—	165
Total costs and operating expenses	28,190	30,711	56,219	59,672
Loss from operations	(12,862)	(22,732)	(33,348)	(34,620)
Interest income	584	972	1,335	1,881
Interest and other expense, net	(984)	(985)	(1,926)	(1,500)
Loss before income taxes	(13,262)	(22,745)	(33,939)	(34,239)
Provision for income taxes	10	10	21	21
Net loss	$(13,272)	$(22,755)	$(33,960)	$(34,260)
Net loss per share, basic and diluted	$(0.16)	$(0.32)	$(0.40)	$(0.49)
Weighted average common stock shares used in computing net loss per share, basic and diluted	85,389	70,376	83,908	70,115

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.